iBio, Inc. — Director's Dealing 2020

Oct 28, 2020

SEC Form 4/A — Form 4/A

Issuer: iBio, Inc. (IBIO)
CIK: 0001420720
Period of Report: 2020-06-12

Reporting Person: Kay Robert (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-12	Stock Option	$1.57	A	400000	Acquired	2030-06-12	Common Stock (400000)	Direct

Footnotes

F1: This amendment on Form 4/A is being filed to amend the original Form 4 filed by the reporting person on June 16, 2020 (the "Original Form 4") solely to amend the exercise price in Column 2 of Table II which was incorrectly reported in the Original Form 4. All other information in the Original Form 4 remains unchanged.

F2: Immediate vesting as to 50,000 shares of Common Stock underlying the option and the remaining shares vest pro rata on a monthly basis over the next 21 months.